Tuesday, February 15, 2022 12:34:58 PM
I'm on the same page as you harry crumb! If GPS is approved this year and SLS is not bought out this could go to the moon. Especially if the SS stays the same. I see how green we are so I am being patient waiting on the shorties to do their job lol. I only have 600 shares but plan on getting a 1K or more. I believe SLS will get FDA approval sometime this year and I am hoping it is this summer or early fall. GLTA SLS$$$
Recent SLS News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 08:07:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2026 08:01:32 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/24/2026 08:11:56 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/23/2026 08:12:11 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/23/2026 08:10:13 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/23/2026 08:09:30 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 03/20/2026 09:01:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/19/2026 08:08:36 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/19/2026 08:00:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2026 08:06:12 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 03:34:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 09:35:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 09:33:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 09:31:37 PM
- The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech • GlobeNewswire Inc. • 01/08/2026 05:08:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2026 01:30:35 PM
- Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge • GlobeNewswire Inc. • 12/24/2025 11:00:00 AM
- Sellas Life Sciences rises after reporting encouraging AML clinical results • IH Market News • 12/08/2025 03:26:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2025 09:07:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2025 09:05:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2025 09:05:13 PM
- Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points • PR Newswire (US) • 12/04/2025 05:20:00 PM
- Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points • PR Newswire (Canada) • 12/04/2025 05:20:00 PM
